About the study:
This study aims to determine whether an approved testosterone therapy for women is effective in preventing bone loss and improving sexual function in women with early menopause who are taking the standard dose of oestrogen. Join and do your part to help advance breakthroughs in this clinical research.
Who can take part in this study?
In order to be eligible to participate in the study, you must meet all of the following:
- You are aged between 18 and 44
- You have experienced menopause OR had both ovaries removed before 45 years of age
- You have been on a stable dose of oestrogen replacement therapy (ERT) for at least 3 months.
- Your body mass index is between 18 and 38.
Who is unable to take part in this study?
Unfortunately, if you have a history of a known bone disease or another condition associated with osteoporosis, this study is not the right fit for you.
How long will the study take?
If you agree to take part, and the study is suitable for you, your participation in the study is expected to last up to 12 months. This may include:
- Screening period (2-4 weeks): 1 visit to the study centre
- Treatment period (12 months): Up to 4 visits to the study centre for up to 60-90 minutes at a time.
- Blood collection and bone density scans at the beginning and end of the trial.
- Some of these visits can be done by telehealth
Where are the study sites?
- The Women’s Health Research Program, Monash University 553 St Kilda Rd, Melbourne 3004 (lead centre),
- Monash University, Monash Health, 246 Clayton Rd, Clayton 3168
- The Keogh Institute of Medical Research 1st floor C Block QEII Medical Centre Hospital Avenue Nedlands WA 6009, Hospital Ave, Nedlands WA 6009
For more information and how to register go to
Content created October 2022